SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing heightened volatility and intense community debate as investors react to the company's latest quarterly results and forward guidance, with discussions centering on its aggressive revenue growth targets for 2030 and its expanding role in AI-driven compute architectures. While bullish participants highlight the stock's long-term potential as a critical component in next-generation AI infrastructure, bears are aggressively questioning the company's valuation multiples and the sustainability of its rapid price appreciation.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending as investors react to a quarterly report that beat revenue and user growth expectations but faced downward pressure due to cautious revenue guidance and the termination of a partnership. The community is actively debating the effectiveness of leadership and the company's long-term potential as a cash-flow-positive player in the AR and AI space.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is seeing high volatility and heavy trading volume as investors debate its upcoming earnings report, with bulls highlighting the company's massive revenue growth and expanding commercial backlog while bears focus on high cash burn and valuation concerns. The community is actively discussing whether the company's aggressive growth trajectory justifies its market cap or if the current price action is simply a pre-earnings speculative pump followed by an inevitable correction.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is experiencing significant volatility and intense community debate as investors weigh stellar earnings and aggressive AI-driven ad revenue growth against broader software sector weakness and concerns over valuation. While bulls are encouraged by record-breaking margins and the potential for a massive breakout, others are focused on institutional profit-taking and fears of a long-term software overhang.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is trending as investors weigh significant revenue growth and a record backlog against concerns regarding ongoing equity distribution and capital structure. The community is actively debating whether the recent heavy institutional selling indicates a long-term fundamental shift or a temporary supply overhang that creates an entry opportunity ahead of future space sector momentum.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently experiencing heightened volatility and intense community debate as investors react to the completion of Rakuten's planned share sales and growing anticipation for the upcoming quarterly earnings report. While some investors are treating the recent price pullback as a strategic buying opportunity, others are expressing frustration over launch delays and questioning the company's ability to hit its aggressive 2026 satellite constellation targets.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is experiencing extreme volatility and intense community debate following a short seller report, with investors focused on the company's robust rebuttal and strong fundamentals, including recent label expansion news and high institutional interest. The prevailing community sentiment is split between 'buy-the-dip' conviction from long-term holders and caution surrounding potential near-term price manipulation.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant market volatility and intense community discussion following recent earnings and ongoing debates regarding Elevidys demand. Investors are actively contrasting the stock's discounted valuation against its commercialized gene therapy portfolio and pipeline potential, with many speculating on the impact of upcoming regulatory catalysts and potential buyout scenarios.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Semiconductor bears are facing extreme pressure as a relentless melt-up in chip stocks continues to ignore valuation concerns and geopolitical risks. Community sentiment is deeply divided, with many traders frustrated by consistent after-hours rallies and a persistent disconnect between sector earnings and price action, leaving some to debate capitulation while others hold out for an expected correction.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is seeing intense market activity following an earnings report that highlighted record-breaking backlog and massive revenue growth, fueling a tug-of-war between optimistic investors citing data center demand and bearish traders focused on margin pressures. The community is actively debating whether the stock is undergoing a long-term structural re-rating driven by AI-powered infrastructure needs or if recent volatility represents an earnings-driven trap for retail shareholders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for...

<ul class="summary-bullets"><li>The funding includes a $10.5 million upfront offering and up to $20.9 million from warrant exercises.</li><li>The company plans to use the proceeds to advance new protein and peptide research programs.</li><li>Last week, Azitra received a notice from the NYSE for failing to meet its minimum stockholders’ equity requirement of $6 million.</li></ul>Shares of Azitra Inc. (AZTR) surged more than 80% on Friday, crossing over its 100-day moving average for the first time since June 2025, after the biopharmaceutical firm announced a private placement to raise over $31 million.<figure class="image"><a class="st-link-external" href="https://in.tradingview.com/chart/teA7VKVN/?symbol=AMEX%3AAZTR" target="_blank" rel="noopener noreferrer nofollow"><img src="https://news.stocktwits-cdn.com/aztr_jpg_0fe58a1f37.webp" alt="aztr.jpg" width="1345" height="849"></a></figure>Source: TradingViewOn Friday, <a href="https://stocktwits.com/symbol/AZTR">AZTR shares</a> recorded their biggest intraday gains since July 27, 2024.<h2 class="st-heading-2">Azitra To Advance New Protein And Peptide Research Programs</h2>Azitra said it is in the process of securing a financing deal worth up to $31.4 million to support its expansion into the cosmetic and cosmeceutical markets. The funding includes an initial $10.5 million offering through convertible preferred stock, with an additional $20.9 million tied to the potential exercise of warrants.The transaction is backed by institutional healthcare investors, including Stonepine Capital and Nantahala Capital.The company plans to use the proceeds to advance new protein and peptide research programs, using its microbial genetic engineering platform. Azitra aims to accelerate the development and commercialization of skincare solutions targeting issues such as dry skin and ageing.“We are confident these technologies offer an exciting new way to address the appearance of fine lines and wrinkles as well as dry, sensitive skin and eczema-like rashes,” said CFO Francisco Salva.<h2 class="st-heading-2">Azitra’s Listing Challenges</h2>Last week, Azitra received a notice from NYSE American LLC for failing to meet its minimum stockholders’ equity requirement of $6 million for companies with recent losses. The company has until April 1, 2027, to regain compliance, during which it will remain listed but will be subjected to regular reviews of its progress.According to Azitra’s latest financial update for the full-year ended Dec. 31, 2025, net loss widened to $11 million from $9 million a year earlier.The company also said it expects to report the topline Phase 1b results for its lead candidate, ATR12-351, for the treatment of Netherton, a rare and severe genetic skin disorder, in the second half of 2026.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday surge, retail sentiment has remained in the ‘bearish’ zone over the past 24 hours.One user said the stock could climb over $1 on the daily chart if the volume holds.<stembedurl>https://stocktwits.com/TonyStacks/message/648079663</stembedurl>Nearly 230 million shares changed hands in the first 20 minutes of trading, compared with an average of 1.8 million, according to Stocktwits data.Year-to-date, the stock has gained around 23%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/apple-aapl-stock-downtrend-200dma-retail-concern/cZ3XqspRILL">AAPL Stock’s Decline Leads It Toward 200-DMA For First Time In Over 7 Months – Retail Concerned Over Lack Of Catalysts</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

This Nano-Cap Pharma Stock Surged 80% Days After A Listing Warning — What’s Fueling the Rally?

The stock crossed its 100-DMA for the first time in more than eight months after announcing a private placement to raise over $31 million.

Why Is AZTR Stock Rising Today?

Equity

Small Caps Swing Big: Capital Raises Fuel AI, Biotech, and EV Ambitions

A flurry of financings, strategic pivots, and technology-driven initiatives is energizing the small-cap space, as companies tap capital markets to chase growth across AI, biotech, and next-generation transportation. $TGNT, $AZTR, $WNW, $UCAR, $JDZG

<ul class="summary-bullets"><li>A record $5.7 trillion “triple witching” options expiry threatens to inject fresh swings into an already fragile market.</li><li>Markets remain on edge as escalating Middle East tensions fuel oil volatility.</li><li>SMCI stock tanks 20% in early pre-market trade on alleged Nvidia chip diversion to China.&nbsp;</li></ul>U.S. stock futures took a breather early Friday with investors parsing the latest developments in the Middle East. However, fresh Israeli strikes on Iran and risks around the Strait of Hormuz are keeping oil volatility in action.Traders will also be&nbsp; focusing on a historic options expiration. They are&nbsp; bracing for a staggering $5.7 trillion in notional options to expire today, which is reportedly the largest March expiry in Citigroup data going back to 1996.&nbsp; As of 4:00 a.m. ET on Friday, Dow futures rose 0.2%, S&amp;P futures gained 0.1%, the Nasdaq futures were flat with a positive bias, and Russell 2000 futures were up 0.3%.Caution prevails among the traders. Retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, remained ‘extremely bearish, and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq-100 Index, has remained ‘bearish’ amid high trading volume.&nbsp;Trending Stocks To Watch Super Micro Computer (SMCI):&nbsp;The stock is on retail radar this morning after U.S. prosecutors charged three individuals, including a co-founder and a board member, in a scheme to smuggle Nvidia (NVDA) chips to China. Both companies have stressed on compliance in their statements.&nbsp;Nvidia (NVDA) &amp; Amazon (AMZN):&nbsp;Despite the SMCI scandal, Nvidia remains in focus following reports it will sell 1 million chips to Amazon by the end of 2027 as part of a massive cloud infrastructure deal. Amazon also boosted its logistics wing by acquiring the autonomous robotics startup Rivr.Meta (META): The company reportedly reversed its decision to shut down&nbsp;Horizon Worlds for Quest VR headsets, citing fan feedback.Tech stocks also remain in the spotlight on reports that the White House is expected to release a&nbsp;national AI regulatory framework in the coming days.&nbsp;Tesla (TSLA):&nbsp;The EV giant is back in focus as it doubles down on its solar and energy ambitions with a $2.9 billion China-linked expansion, while also nearing a potential rollout of its Full Self-Driving (FSD) software in Europe.FedEx (FDX): The stock is garnering retail attention following a Q3 earnings beat and a raised FY26 outlook. Analysts at Wells Fargo and JPMorgan raised price targets to $430–$432.&nbsp;Investors are shifting focus to&nbsp;rare earth stocks (MP, UAMY, USAR) following a landmark joint action plan between the U.S. and Japan. The two nations announced a $73 billion energy and minerals initiative, including the development of deep-sea rare earth muds near Minamitori Island.&nbsp;Azitra Inc. (AZTR):&nbsp;The stock is seeing strong pre-market action following the pricing of a $31.4 million private placement financing.ImmunityBio, Inc. (IBRX): Its cancer therapy Anktiva appeared on Macau’s latest drug list. Also, the founder has flagged early immune activation data from an Anktiva study.Other tickers trending on&nbsp;Stocktwits&nbsp;at the time of writing included Firefly Aerospace (FLY), AppLovin Corp (APP), and Qualcom (QCOM).&nbsp;On earnings radar, watch out for quarterly reports from Milestone Scientific (MIST), XPeng (XPEV), and Zegna (ZGN) before the bell today.For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Take A Breather Ahead Of Massive Options Expiry: Why SMCI, NVDA, TSLA, UAMY, IBRX Are Keeping Traders Engaged Today

Data from Stocktwits indicated that retail sentiment remains bearish on SPY and QQQ. 

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million Azitra Announces Pricing of Private Placement...

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE...

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders PR Newswire BRANFORD, Conn., March 5, 2026...

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates PR Newswire BRANFORD, Conn., Feb. 27, 2026...

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash Azitra, Inc. Announces Addition of MD Anderson Cancer...

Azitra, Inc. to Present at BIO Investment & Growth Summit

Azitra, Inc. to Present at BIO Investment & Growth Summit Azitra, Inc. to Present at BIO Investment & Growth Summit PR Newswire BRANFORD, Conn., Feb. 19, 2026 BRANFORD, Conn., Feb. 19, 2026...

Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.

Azitra Inc

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

AZTR
Azitra Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AZTR News

AZTRAzitra Inc